Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ONYX BIOTEC LTD. vs BETA DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ONYX BIOTEC LTD. BETA DRUGS ONYX BIOTEC LTD./
BETA DRUGS
 
P/E (TTM) x - - - View Chart
P/BV x 3.0 12.8 23.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ONYX BIOTEC LTD.   BETA DRUGS
EQUITY SHARE DATA
    ONYX BIOTEC LTD.
Mar-24
BETA DRUGS
Mar-24
ONYX BIOTEC LTD./
BETA DRUGS
5-Yr Chart
Click to enlarge
High RsNA1,595 0.0%   
Low RsNA645 0.0%   
Sales per share (Unadj.) Rs40.4307.7 13.1%  
Earnings per share (Unadj.) Rs2.337.9 6.0%  
Cash flow per share (Unadj.) Rs4.048.1 8.2%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00- 
Book value per share (Unadj.) Rs18.7163.5 11.4%  
Shares outstanding (eoy) m13.329.61 138.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x03.6 0.0%   
Avg P/E ratio x029.5 0.0%  
P/CF ratio (eoy) x023.3 0.0%  
Price / Book Value ratio x06.9 0.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m010,765 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m60201 29.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5372,957 18.2%  
Other income Rs m114 8.7%   
Total revenues Rs m5392,972 18.1%   
Gross profit Rs m83599 13.9%  
Depreciation Rs m2298 23.0%   
Interest Rs m2228 76.5%   
Profit before tax Rs m41488 8.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m10123 8.3%   
Profit after tax Rs m30364 8.3%  
Gross profit margin %15.520.3 76.5%  
Effective tax rate %25.225.3 99.6%   
Net profit margin %5.612.3 45.8%  
BALANCE SHEET DATA
Current assets Rs m2961,876 15.8%   
Current liabilities Rs m226944 23.9%   
Net working cap to sales %12.931.5 41.1%  
Current ratio x1.32.0 65.8%  
Inventory Days Days713 59.2%  
Debtors Days Days1,044978 106.7%  
Net fixed assets Rs m446748 59.6%   
Share capital Rs m13396 138.6%   
"Free" reserves Rs m1161,475 7.8%   
Net worth Rs m2491,571 15.8%   
Long term debt Rs m23660 390.5%   
Total assets Rs m7412,624 28.3%  
Interest coverage x2.918.3 15.7%   
Debt to equity ratio x0.90 2,466.2%  
Sales to assets ratio x0.71.1 64.3%   
Return on assets %7.015.0 46.8%  
Return on equity %12.223.2 52.5%  
Return on capital %12.831.6 40.5%  
Exports to sales %015.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA445 0.0%   
Imports (cif) Rs mNA10 0.0%   
Fx inflow Rs m0445 0.0%   
Fx outflow Rs m041 0.0%   
Net fx Rs m0404 0.0%   
CASH FLOW
From Operations Rs m15309 4.9%  
From Investments Rs m-31-140 22.5%  
From Financial Activity Rs m31-75 -41.3%  
Net Cashflow Rs m1595 15.4%  

Share Holding

Indian Promoters % 0.0 66.7 -  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 1.3 -  
FIIs % 0.0 1.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 33.3 -  
Shareholders   0 2,567 -  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ONYX BIOTEC LTD. With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on ONYX BIOTEC LTD. vs BETA DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ONYX BIOTEC LTD. vs BETA DRUGS Share Price Performance

Period ONYX BIOTEC LTD. BETA DRUGS S&P BSE HEALTHCARE
1-Day 0.00% 5.14% 1.23%
1-Month 0.00% 5.14% -0.24%
1-Year 0.00% 5.14% 43.62%
3-Year CAGR 0.00% 1.68% 20.35%
5-Year CAGR 0.00% 1.01% 26.24%

* Compound Annual Growth Rate

Here are more details on the ONYX BIOTEC LTD. share price and the BETA DRUGS share price.

Moving on to shareholding structures...

The promoters of ONYX BIOTEC LTD. hold a 0.0% stake in the company. In case of BETA DRUGS the stake stands at 66.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ONYX BIOTEC LTD. and the shareholding pattern of BETA DRUGS .

Finally, a word on dividends...

In the most recent financial year, ONYX BIOTEC LTD. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

BETA DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of ONYX BIOTEC LTD., and the dividend history of BETA DRUGS .

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.